期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助化疗研究的新进展 被引量：6

Advances of neoadijuvant chemotherapy for breast cancer
下载PDF
导出
摘要 新辅助化疗已成为局部晚期乳腺癌的标准治疗方式 ,但仍有许多问题尚待解决。笔者就新辅助化疗与保乳手术的关系、新药应用。
作者 高砚春 吴诚义
机构地区 重庆医科大学附属第一医院普外科
出处 《中国普通外科杂志》 CAS CSCD 2004年第11期846-849,共4页 China Journal of General Surgery
关键词 乳腺肿瘤/药物疗法 辅助化疗 综述文献
分类号 R737.9 [医药卫生—肿瘤] R44 [医药卫生—诊断学]
  • 相关文献

参考文献25

  • 1Newman,Lisa A,Buzdar,et al.A prospective trial of preoperative chemotherapy in resectable breast cancer:predictors of breast-conservation therapy feasibility[J].Ann Surg Oncol,2002,9(3):228- 234.
  • 2Fisher ER,Wang J,Bryant J,et al.Pathobiology of preoperative chemotherapy:findings from the National Surgical Adjuvant Breast and Bowel Protocol(NSABP)B-18[J].Cancer,2002,95(4):681- 695.
  • 3Isabelle VP,Herv C,Bernard L,et al.Efficacy of a primary chemotherapy regimen combining vinorelbine,epirubicin,and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer[J].The Oncologist,2002,7(5):418- 423.
  • 4Link JS,Forsthoff CA,Ibarra J,et al.Dose-dense doxorubicin,docetaxel and cyclophosphamide as sequential neoadjuvant therapy for high-risk breast cancer: a pilot study [J].Breast Cancer Res Treat,2003,82(Supple 1):59-60.
  • 5Mamounas EP,Wang J,Bryant J,et al.Patterns of loco-regional failure (LRF) in patients receiving neoadjuvant chemotherapy (NC): results from NSABP B-18 [J].Breast Cancer Res Treat,2003,82(Supple 1):17.
  • 6Cance WG,Carey LA,Calvo BF,et al.Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma:effective clinical downstaging allows breast preservating and predicts outstanding local control and survival[J].Ann Surg.2002,236(3):295-302.
  • 7Inaji H,Komoike Y,Motomura K,et al.Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer[J].Breast Cancer,2002,9(1):20- 25.
  • 8Cleator SJ,Lal KR,Ashley S,et al.Good clinical response by breast cancers to neoadjuvant chemoendocrine therapy is associated with superior overall survival after 10 years follow-up[J].Breast Cancer Res Treat,2003,82(Supple 1):52.
  • 9Semlglazov VF,Bojok AA,Arsumanov AS,et al.Breast conserving surgery after neoadjuvant chemotherapy paclitaxel + doxorubicln vs fluorouracil + doxorubicin + cyclophosphamide in locally advanced breast cancer[J].Breast Cancer Res Treat,2002,76(Supple 1):52.
  • 10Anelli A,Brentani RR,Gadelha AP,et al.Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer[J].Ann Oncol,2003,14(3):428-432.

共引文献19

同被引文献33

  • 1孙艳丽,卢振霞,王立波.长春瑞滨联合卡培他滨治疗转移性乳腺癌30例临床观察[J].实用肿瘤学杂志,2005,19(1):9-11. 被引量：4
  • 2陈绍水,宁方玲,郭毅,吕俊华.NP和CAF方案治疗晚期乳腺癌疗效及副反应分析[J].滨州医学院学报,2005,28(3):165-166. 被引量：2
  • 3李毅刚,卢路定,赖淑贞,曾庆祉.长春瑞滨与表阿霉素联合治疗晚期乳腺癌临床观察[J].中国肿瘤临床与康复,2005,12(5):419-420. 被引量：4
  • 4胡永生 主编.现代乳腺影像诊断学[M].北京：科学出版社,2001.25-26.
  • 5Stara dub VL,Hsieh, Clanson,et al.Factors that influence surgical choices in women with breast carcinoma [J ]. Cancer, 2002,956:1185-1190.
  • 6Garces CA,Cance WG.Neoadjuvant chemotherapy of breastcancer [J ].Am Surg, 2004,70(7 ) : 565-569.
  • 7Dash N,Chafin S,Johnson RR, et al. Usefulness of tissue markerclipsin patients undergoing neoadjuvant chemotherapy for breastcancer [J]. AJR Am Roentgenol, 1999,173(4): 911-917.
  • 8邵志敏.乳腺癌的规范化治疗[C].山东抗癌协会普外肿瘤专业委员会第三次学术会议论文汇编,2006.
  • 9Gonzalez E,Grafton WD,Morrfis DM, et al.D iagnosing breast cancer using frozen section from Tru-Cut needle biopsies [J].Ann Surg, 1998,202(6 ):696-701.
  • 10Turley JM, Funakoshi S, Ruscetti RW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta [J] . Cell Growth Differ, 1995, 6 (6) : 655 - 663.

引证文献6

二级引证文献19

中国普通外科杂志
2004年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部